1. Home
  2. BHST vs GDL Comparison

BHST vs GDL Comparison

Compare BHST & GDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHST
  • GDL
  • Stock Information
  • Founded
  • BHST 2007
  • GDL 2006
  • Country
  • BHST Canada
  • GDL United States
  • Employees
  • BHST N/A
  • GDL N/A
  • Industry
  • BHST
  • GDL Investment Managers
  • Sector
  • BHST
  • GDL Finance
  • Exchange
  • BHST Nasdaq
  • GDL Nasdaq
  • Market Cap
  • BHST 106.0M
  • GDL N/A
  • IPO Year
  • BHST N/A
  • GDL N/A
  • Fundamental
  • Price
  • BHST $6.46
  • GDL $8.23
  • Analyst Decision
  • BHST Strong Buy
  • GDL
  • Analyst Count
  • BHST 2
  • GDL 0
  • Target Price
  • BHST $13.00
  • GDL N/A
  • AVG Volume (30 Days)
  • BHST 11.2K
  • GDL 11.2K
  • Earning Date
  • BHST 03-31-2025
  • GDL 01-01-0001
  • Dividend Yield
  • BHST N/A
  • GDL 6.02%
  • EPS Growth
  • BHST N/A
  • GDL N/A
  • EPS
  • BHST N/A
  • GDL N/A
  • Revenue
  • BHST $22,430,000.00
  • GDL N/A
  • Revenue This Year
  • BHST $161.11
  • GDL N/A
  • Revenue Next Year
  • BHST $64.74
  • GDL N/A
  • P/E Ratio
  • BHST N/A
  • GDL N/A
  • Revenue Growth
  • BHST 111.68
  • GDL N/A
  • 52 Week Low
  • BHST $0.00
  • GDL $7.65
  • 52 Week High
  • BHST $7.38
  • GDL $8.13
  • Technical
  • Relative Strength Index (RSI)
  • BHST N/A
  • GDL 45.59
  • Support Level
  • BHST N/A
  • GDL $8.32
  • Resistance Level
  • BHST N/A
  • GDL $8.35
  • Average True Range (ATR)
  • BHST 0.00
  • GDL 0.07
  • MACD
  • BHST 0.00
  • GDL -0.01
  • Stochastic Oscillator
  • BHST 0.00
  • GDL 18.75

About BHST BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

Share on Social Networks: